222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

7 trials found

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04424862 (ClinicalTrials.gov)	June 9, 2020	7/6/2020	Multitarget Therapy for Idiopathic Membranous Nephropathy	Multitarget Therapy for Idiopathic Membranous Nephropathy	Efficacy	Drug: Prednisone , ciclosporin and mycophenolate mofetil;Drug: Ponticelli Regimen	Beijing Friendship Hospital	NULL	Completed	18 Years	70 Years	All	82	Phase 4	China
2	NCT03170323 (ClinicalTrials.gov)	July 1, 2018	26/5/2017	MycophenolateMofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranou ...	A Prospective Randomized, Controlled Trial of MycophenolateMofetil Plus Steroid in the Treatment Of ...	Idiopathic Membranous Nephropathy	Drug: Mycophenolate Mofetil;Drug: Cyclosporins	Guangdong Provincial People's Hospital	NULL	Recruiting	18 Years	N/A	All	128	Phase 4	China
3	NCT02921789 (ClinicalTrials.gov)	May 22, 2017	30/9/2016	Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmenta ...	A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Sa ...	Kidney Transplantation;Primary Focal Segmental Glomerulosclerosis (FSGS)	Drug: Bleselumab;Drug: Basiliximab;Drug: Mycophenolate Mofetil (MMF);Drug: Tacrolimus Capsules;Drug: Me ...	Astellas Pharma Global Development, Inc.	Kyowa Kirin Co., Ltd.	Completed	18 Years	N/A	All	67	Phase 2	United States;Canada
4	NCT01282073 (ClinicalTrials.gov)	March 2011	19/1/2011	Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy	A Randomized Controlled Multi-center Trial of MycophenolateMofetil for the Patient With High Risk Me ...	Glomerulonephritis, Membranous	Drug: Mycophenolate mofetil , low dose steroid;Drug: Cyclosporin , low dose steroid	Kyungpook National University	Hanmi Pharmaceutical Company Limited	Recruiting	18 Years	N/A	Both	62	Phase 3	Korea, Republic of
5	EUCTR2009-016003-26-GB (EUCTR)	06/05/2010	17/03/2010	RANDOMISED PILOT TRIAL OF MYFORTIC FOR THE TREATMENT OF PRIMARY PROTEINURIC GLOMERULONEPHRITIS. - Gl ...	RANDOMISED PILOT TRIAL OF MYFORTIC FOR THE TREATMENT OF PRIMARY PROTEINURIC GLOMERULONEPHRITIS. - Gl ...	Primary Proteinuric Glomeruolnephritis Focal segmental glomeruloscerosis and IgA nephropathy MedDRA ...	Trade Name: Myfortic Product Name: Myfortic 360mg Tablets INN or Proposed INN: mycophenolic acid Other d ...	UHB NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 2	United Kingdom
6	NCT00404833 (ClinicalTrials.gov)	January 2003	27/11/2006	Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental	A Prospective Randomized Open-label Study to Compare MycophenolateMofetil and Corticosteroid With Co ...	Glomerulonephritis, Membranous;Glomerulosclerosis, Focal	Drug: prednisolone and mycophenolate mofetil;Drug: prednisolone and chlorambucil	Hospital Authority, Hong Kong	The University of Hong Kong	Completed	18 Years	65 Years	Both	16	Phase 3	China
7	NCT00135967 (ClinicalTrials.gov)	May 2002	25/8/2005	Mycophenolate Mofetil in Membranous Nephropathy	Treatment of Patients With Membranous Nephropathy and Renal Insufficiency With MycophenolateMofetil ...	Glomerulonephritis, Membranous	Drug: mycophenolate mofetil orally 1000 mg twice a day (BID);Drug: prednisone 0,5 mg/kg orally on alter ...	Radboud University	Hoffmann-La Roche	Completed	18 Years	75 Years	Both	30	Phase 2/Phase 3	Netherlands

First Previous1Next Last